![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Second cancers and late mortality in Australian children treated by allogeneic HSCT for haematological malignancy
We examined risk of second cancer and late mortality in a population-based Australian cohort of 717 pediatric allogeneic stem cell transplant (HSCT) recipients treated for a malignant disease during 1982–2007....
-
Article
Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study
Population-based evidence on second cancer risk following autologous haematopoietic SCT (HCT) is lacking. We quantified second cancer risk for a national, population-based cohort of adult Australians receiving...
-
Chapter and Conference Paper
Plasma Exchange
Plasma exchange has been used as a therapeutic tool since the beginning of the century (Abel et al., 1914). However its use has increased markedly since the development of efficient machines to perform the man...